These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8545255)

  • 1. Radioimmunoassay for hexarelin, a peptidic growth hormone secretagogue, and its pharmacokinetic studies.
    Roumi M; Lenaerts V; Boutignon F; Wuthrich P; Deghenghi R; Bellemare M; Adam A; Ong H
    Peptides; 1995; 16(7):1301-6. PubMed ID: 8545255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics and disposition of hexarelin, a peptidic growth hormone secretagogue, in rats.
    Roumi M; Marleau S; du Souich P; Maggi T; Deghenghi R; Ong H
    Drug Metab Dispos; 2000 Jan; 28(1):44-50. PubMed ID: 10611139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of the growth hormone releasing peptide hexarelin with somatostatin.
    Massoud AF; Hindmarsh PC; Brook CG
    Clin Endocrinol (Oxf); 1997 Nov; 47(5):537-47. PubMed ID: 9425393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of repeated administration of hexarelin, a growth hormone releasing peptide, and growth hormone releasing hormone on growth hormone responsivity.
    Massoud AF; Hindmarsh PC; Matthews DR; Brook CG
    Clin Endocrinol (Oxf); 1996 May; 44(5):555-62. PubMed ID: 8762732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone-releasing activity of hexarelin in humans. A dose-response study.
    Imbimbo BP; Mant T; Edwards M; Amin D; Dalton N; Boutignon F; Lenaerts V; Wüthrich P; Deghenghi R
    Eur J Clin Pharmacol; 1994; 46(5):421-5. PubMed ID: 7957536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of repeated doses and continuous infusions of the growth hormone-releasing peptide hexarelin in conscious male rats.
    Conley LK; Gaillard RC; Giustina A; Brogan RS; Wehrenberg WB
    J Endocrinol; 1998 Sep; 158(3):367-75. PubMed ID: 9846166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, after intravenous, subcutaneous, intranasal, and oral administration in man.
    Ghigo E; Arvat E; Gianotti L; Imbimbo BP; Lenaerts V; Deghenghi R; Camanni F
    J Clin Endocrinol Metab; 1994 Mar; 78(3):693-8. PubMed ID: 8126144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioimmunoassay of meterelin and pharmacokinetics after single injection and implant administration in dogs.
    Hudon E; Rondeau JJ; Lenaerts V; Würthrich P; Boutignon F; Deghenghi R; Marleau S; Yamaguchi N; Adam A; Ong H
    J Pharm Sci; 1997 Feb; 86(2):172-8. PubMed ID: 9040091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hexarelin induced growth hormone release is influenced by exogenous growth hormone.
    Massoud AF; Hindmarsh PC; Brook CG
    Clin Endocrinol (Oxf); 1995 Nov; 43(5):617-21. PubMed ID: 8548947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effects of growth hormone-releasing hormone and hexarelin, a novel growth hormone-releasing peptide-6 analog, on growth hormone secretion in humans with or without glucocorticoid excess.
    Giustina A; Bussi AR; Deghenghi R; Imbimbo B; Licini M; Poiesi C; Wehrenberg WB
    J Endocrinol; 1995 Aug; 146(2):227-32. PubMed ID: 7561633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide modulation of the growth hormone-releasing activity of Hexarelin in young and old dogs.
    Rigamonti AE; Cella SG; Marazzi N; Müller EE
    Metabolism; 1999 Feb; 48(2):176-82. PubMed ID: 10024078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioimmunoassay of Antarelix, a luteinizing hormone releasing-hormone antagonist, in plasma and its application for pharmacokinetic study in dogs.
    Sorensen S; Rondeau JJ; Lenaerts V; Boutignon F; Wüthrich P; Deghenghi R; Adam A; Ong H
    J Immunoassay; 1996 Aug; 17(3):205-26. PubMed ID: 8842981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hexarelin, a synthetic growth hormone releasing peptide, stimulates prolactin secretion in acromegalic but not in hyperprolactinaemic patients.
    Ciccarelli E; Grottoli S; Razzore P; Gianotti L; Arvat E; Deghenghi R; Camanni G; Ghigo E
    Clin Endocrinol (Oxf); 1996 Jan; 44(1):67-71. PubMed ID: 8706295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GH responsiveness to repeated GHRH or hexarelin administration in normal adults.
    Sartorio A; Conti A; Ferrero S; Spada A; Faglia G
    J Endocrinol Invest; 1995 Oct; 18(9):718-22. PubMed ID: 8719303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute administration of hexarelin stimulates GH secretion during day and night in normal men.
    Loche S; Colao A; Cappa M; Ferone D; Merola B; Faedda A; Imbimbo BP; Deghenghi R; Lombardi G
    Clin Endocrinol (Oxf); 1997 Mar; 46(3):275-9. PubMed ID: 9156035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone responses to growth hormone-releasing hormone and hexarelin in fed and fasted dogs: effect of somatostatin infusion or pretreatment with pirenzepine.
    Rigamonti AE; Marazzi N; Cella SG; Cattaneo L; Müller EE
    J Endocrinol; 1998 Feb; 156(2):341-8. PubMed ID: 9518881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of desensitization by hexarelin to subsequent GH releasing hormone-mediated GH secretion in patients with anorexia nervosa.
    Popovic V; Micic D; Djurovic M; Obradovic S; Casanueva FF; Dieguez C
    Clin Endocrinol (Oxf); 1997 May; 46(5):539-43. PubMed ID: 9231048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arginine and growth hormone-releasing hormone restore the blunted growth hormone-releasing activity of hexarelin in elderly subjects.
    Arvat E; Gianotti L; Grottoli S; Imbimbo BP; Lenaerts V; Deghenghi R; Camanni F; Ghigo E
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1440-3. PubMed ID: 7962341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of action of hexarelin and GHRP-6: analysis of the involvement of GHRH and somatostatin in the rat.
    Conley LK; Teik JA; Deghenghi R; Imbimbo BP; Giustina A; Locatelli V; Wehrenberg WB
    Neuroendocrinology; 1995 Jan; 61(1):44-50. PubMed ID: 7731497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hexarelin-induced growth hormone, cortisol, and prolactin release: a dose-response study.
    Massoud AF; Hindmarsh PC; Brook CG
    J Clin Endocrinol Metab; 1996 Dec; 81(12):4338-41. PubMed ID: 8954038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.